Physician profile
John V Williams
NPI 1609863489
$1,197.90
in general payments reported to CMS, 2019-2025
12 companies · $234 in 2025
The $234 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $60.86 · 2021: $166 · 2022: $186 · 2023: $318 · 2024: $233 · 2025: $234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $785.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $785.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $388.44 | 2020-2025 | Airsupra, Breztri, Farxiga |
| Novo Nordisk INC | $283.93 | 2020-2024 | Rybelsus |
| Lilly USA, LLC | $112.25 | 2021-2025 | Mounjaro, Zepbound |
| Exact Sciences Corporation | $78.49 | 2023-2024 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $71.67 | 2022-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $64.45 | 2022-2025 | |
| Abbott Laboratories | $60.36 | 2023-2024 | Freestyle Libre |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $36.30 | 2021-2023 | Xifaxan |
| Amgen INC. | $32.72 | 2025 | Repatha |
| Dexcom, INC. | $27.43 | 2025 | Dexcom G6 Transmitter |
| Pfizer INC. | $22.44 | 2022 | |
| Boston Scientific Corporation | $19.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.